Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?

被引：4
|
作者：
Grant, Brooke M. [1 ]
Pugh, Trevor J. [1 ,2 ,3 ]
Oza, Amit M. [1 ,4 ,5 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 02期
关键词：
D O I：
10.1158/1078-0432.CCR-22-2781
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Efforts are under way to define the role of minimally invasive strategies for molecular monitoring and risk stratification in endo-metrial cancer. A recent publication aims to define the association between circulating tumor DNA level and disease stage in patients with newly diagnosed endometrial cancer and determine whether sequencing of longitudinal cell-free DNA samples can be used for disease monitoring and detection of progression or recurrence. These results accelerate the current knowledge of molecular fol-low-up in endometrial cancer.
引用
收藏
页码：305 / 308
页数：4
相关论文
共 50 条
  • [21] Are molecular neuroblastoma classifiers ready for prime time?
    Volchenboum, Samuel L.
    Cohn, Susan L.
    LANCET ONCOLOGY, 2009, 10 (07): : 641 - 642
  • [22] Making Molecular Diagnostics Ready for Prime Time
    Jonietz, Erika
    CANCER DISCOVERY, 2011, 1 (06)
  • [23] Continuous noninvasive hemoglobin monitoring: ready for prime time?
    Suehiro, Koichi
    Joosten, Alexandre
    Alexander, Brenton
    Cannesson, Maxime
    CURRENT OPINION IN CRITICAL CARE, 2015, 21 (03) : 265 - 270
  • [24] Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
    Peintinger, Florentia
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 21 - 26
  • [25] At-Home Glaucoma Monitoring: Is it Ready for Prime Time?
    Turner, Marcus
    Ou, Yvonne
    OPHTHALMOLOGY GLAUCOMA, 2023, 6 (02): : 117 - 120
  • [26] Cryotherapy for prostate cancer: ready for prime time?
    Pisters, Louis L.
    CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 218 - 222
  • [27] Buprenorphine for Cancer Pain: Is It Ready for Prime Time?
    Prommer, Eric
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2015, 32 (08): : 881 - 889
  • [28] In silico cancer modeling: is it ready for prime time?
    Thomas S Deisboeck
    Le Zhang
    Jeongah Yoon
    Jose Costa
    Nature Clinical Practice Oncology, 2009, 6 : 34 - 42
  • [29] Breast Cancer Immunotherapy: Is It Ready for Prime Time?
    Mittendorf, Elizabeth A.
    Hunt, Kelly K.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (09) : 6 - 9
  • [30] Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
    Hassan, Raffit
    Thomas, Anish
    Alewine, Christine
    Le, Dung T.
    Jaffee, Elizabeth M.
    Pastan, Ira
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4171 - +
12345